United Kingdom AstraZeneca has made a bold move by offering its in-house digital clinical trial expertise to clinical research organisations (CROs) and other pharmaceutical companies via the launch of healthtech business Evinova. AstraZeneca’s apparent willingness to share expertise with its competitors has raised some eyebrows, but the British firm is steadfast in…
See our Cookie Privacy Policy Here